Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1729-2025

Philips Tempus Pro Patient Monitor, REF: 00-1004-R, 00-1007-R, 00-1024-R, 00-1026-R, 00-1004, 00-1007 Recall

Philips Tempus Pro Patient Monitor, REF: 00-1004-R, 00-1007-R, 00-1024-R, 00-1026-R, 00-1004, 00-1007

FDA recall Class II

Ongoing

FDA lists this Class II recall for Philips Tempus Pro Patient Monitor, REF: 00-1004-R, 00-1007-R, 00-1024-R, 00-1026-R, 00-1004, 00-1007. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1729-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 15, 2025
FDA report date
May 14, 2025
Quantity in commerce
6961
Distribution
See key details
FDA cause
Software design

What is being recalled?

Philips Tempus Pro Patient Monitor, REF: 00-1004-R, 00-1007-R, 00-1024-R, 00-1026-R, 00-1004, 00-1007

Affected model & UDI checker

Search the exact identifiers published for Z-1729-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
00-1004-RPhilips Tempus Pro Patient Monitor, REF: 00-1004-R, 00-1007-R, 00-1024-R, 00-1026-R, 00-1004, 00-1007Check source noticeNot specified
00-1007-RPhilips Tempus Pro Patient Monitor, REF: 00-1004-R, 00-1007-R, 00-1024-R, 00-1026-R, 00-1004, 00-1007Check source noticeNot specified
00-1024-RPhilips Tempus Pro Patient Monitor, REF: 00-1004-R, 00-1007-R, 00-1024-R, 00-1026-R, 00-1004, 00-1007Check source noticeNot specified
FDA code information

Software versions prior to vx.40. REF/UDI-DI: 00-1004-R/05060472440020, 05060472442901; 00-1007-R/05060472440013, 05060472442918; 00-1024-R/05060472441027, 05060472442925; 00-1026-R/05060472441058, 05060472442932; 00-1004/05060472440624; 00-1007/05060472440655

View the original FDA recall notice

Why was this product recalled?

Patient Monitor software update to address issues:1)May freeze at startup with MPM Application error and Attention Restart Required messages,2)Monitor may freeze and reboot at start of 12-lead ECG or after, 3)May reboot after intermittent connection with Smart Mount, 4) 12-lead ECG measurements with Louvain algorithm and software before vx.36 could produce inaccurate rhythm/morphology statements.

What actions did Remote Diagnostic Technologies Ltd. take?

On 4/15/2025, correction notices were mailed to customers and distributors informing them of the following: I) The User/Operator Manual provides precautions and warnings on maintaining appropriate power or battery supply, which may reduce the risk of occurrence of an "MPM Application" software error message: -Warning (In Chapter 2, Getting started): Ensure the latches on both sides of the battery are fully engaged prior to using the Tempus - an incorrectly fitted battery could result in the tempus losing power during use. -Note: Before removing the battery, you must switch off the Tempus Pro by pressing the power button. Do not remove the battery when the Tempus is on (unless there is a power supply attached to the device). II) If you have confirmed that your Tempus Pro has the standard (Louvain) algorithm, continue to follow the User/Operator Manual, which warns users to not make evaluations based solely on interpretation statements from the algorithm. -Warning (In Chapter 6, Taking medical readings): ECG interpretation performed by software is not a substitute for review and evaluation of ECG recordings by a qualified clinician. Keep a copy of this notice with your device until you receive the correction. Complete and return the response form via email to https://philips.efmfeedback.com/se/705E3ED80DE11FAF In addition, distributors were asked to do the following: - Modify the Response Form to substitute your firm's email and fax information. - Send a copy of this Urgent Medical Device Correction (with modified response form) to each customer to whom you distributed the affected product. Philips has developed a software update to resolve these issues that is expected to be available Q3 2025 via FCO86700012. If you need any further information or support concerning this issue, please contact the firm at (800) 722-9377 or email [email protected]

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology